Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.
| Added by | standudu |
|---|---|
| Group name | EquipeCTCS |
| Item Type | Attachment |
| Title | Texte intégral |
| URL | https://genomemedicine.biomedcentral.com/counter/pdf/10.1186/s13073-023-01181-8 |
| Accessed | 2023/10/16 - 18:50:51 |
| Date Added | 2023/10/16 - 16:50:51 |
| Date Modified | 2023/10/16 - 16:50:51 |
| Parent item | Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2-, PIK3CA-mutated breast cancers |
Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).
U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)
Institut de Recherche en Cancérologie de